Article citationsMore>>

Novartis (2014) TRANSFORMS FTY720. A 12-Month Study Comparing the Efficacy and Safety of Two Doses of Fingolimod versus Interferon β-1a in Patients with Relapsing-Remitting Multiple Sclerosis with Optional Extension Phase. NCT00340834.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top